NOW AVAILABLE – Final Primer Video- Genomics Enabling Personalised Treatment for Cancer Patients

The Genomic Medicine Special Interest Group have produced a 3-part primer videos – ‘Genomics Enabling Personalised Treatment for Cancer Patients.

The videos aim to improve the understanding of some fundamentals of genomic medicines and the NHS Genomic Medicine Service.

The third and final primer video is now available to watch.

Click here to watch the final video (or this link).

 

Want to listen to more about genomic medicine and learn how it impacts cancer patients and their treatment? Revisit the 1st Genomic Wbinar (24th January 2023) by watching the recording here (available free to BOPA members).

The next Genomics Webinar is on 9th February. There is still time to register.

 

The Genomic Medicine Special Interest Group is a BOPA affiliated group aiming to promote excellence in the pharmaceutical care of patients by supporting the membership to systematically embed genomic medicine and pharmacogenomics into routine care. Find out more about the GMSIG here.

Latest News

By BOPA on 22nd January 2026

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students   Through an open letter published on its website, the UK Pharmacy Professional Leadership Advisory Board is inviting…

Read article
By BOPA Executive Committee on 20th January 2026

Join NCODA in Dublin, Ireland from 11-12 March for the 2026 NCODA Global Oncology & Haematology Congress 

Join NCODA in Dublin, Ireland from 11-12 March for the 2026 NCODA Global Oncology & Haematology Congress — a new international meeting designed to unite leaders in oncology, hematology, diagnostics, and technology for two days of…

Read article
By BOPA Executive Committee on 20th January 2026

The HMP Safety Campaign page is now live!

The HMP Safety Campaign page is now live on the SHBN website: https://shbn.org.uk/hmp-safety/ The campaign has been established to address the ongoing risks faced by healthcare professionals who prepare, administer,…

Read article
By BOPA Research committee on 15th January 2026

Allied health and lifestyle support provision research survey

Dear members, Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) are working on behalf of Pfizer to identify the type of information, support and services offered to people living with metastatic…

Read article